24 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 27541605 | Pretreatment serum levels of interferon-gamma-inducible protein-10 are associated with virologic response to telaprevir-based therapy. | 2016 Dec | 1 |
2 | 26130141 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial. | 2015 Jul 1 | 1 |
3 | 26177560 | Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response. | 2015 Sep | 2 |
4 | 26284971 | Effect of IL28B genotype on hepatitis B and C virus infection. | 2015 Oct | 1 |
5 | 26699619 | Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting. | 2015 | 1 |
6 | 23689989 | IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. | 2014 Apr | 1 |
7 | 24102823 | Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4. | 2014 Jul | 1 |
8 | 24205831 | Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. | 2014 Jan | 1 |
9 | 24417888 | Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load. | 2014 Dec | 1 |
10 | 24654629 | Review article: genetic factors that modify the outcome of viral hepatitis. | 2014 May | 1 |
11 | 25132781 | Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms. | 2014 Aug 14 | 1 |
12 | 25283962 | Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance. | 2014 Oct | 2 |
13 | 23142377 | Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF/RBV therapy using systematic meta-analysis. | 2013 Jan 25 | 1 |
14 | 23356752 | Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B. | 2013 Jun | 1 |
15 | 23874902 | Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. | 2013 | 1 |
16 | 24057245 | Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study. | 2013 Nov | 1 |
17 | 24379617 | Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients. | 2013 Dec 21 | 1 |
18 | 21951981 | IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C. | 2012 Mar | 2 |
19 | 22095536 | Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b. | 2012 Jan | 1 |
20 | 20659305 | A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype. | 2011 Sep | 2 |
21 | 21360545 | Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b. | 2011 May | 1 |
22 | 22003405 | IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. | 2011 | 2 |
23 | 22087138 | Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B. | 2011 Mar | 1 |
24 | 20708617 | Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. | 2010 Nov | 1 |